|
Volumn 32, Issue 4, 2005, Pages 399-407
|
Extended dosing of darbepoetin alfa in patients with chronic kidney disease not on dialysis: a review of recent data.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG DERIVATIVE;
ERYTHROPOIETIN;
HEMOGLOBIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
ANEMIA;
ATTITUDE TO HEALTH;
BLOOD;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG MONITORING;
FEASIBILITY STUDY;
HUMAN;
NURSE ATTITUDE;
NURSING;
PHARMACOKINETICS;
PSYCHOLOGICAL ASPECT;
REVIEW;
SAFETY;
TREATMENT OUTCOME;
ANEMIA;
ATTITUDE TO HEALTH;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG MONITORING;
ERYTHROPOIETIN;
FEASIBILITY STUDIES;
HEMOGLOBINS;
HUMANS;
KIDNEY FAILURE, CHRONIC;
NURSE'S ROLE;
SAFETY;
THERAPEUTIC EQUIVALENCY;
TREATMENT OUTCOME;
|
EID: 27744487699
PISSN: 1526744X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (52)
|